Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-06

Clinical Trial Update: Acrylamide and Health Outcomes

View source ↗

Summary

The Karolinska Institutet-led trial on acrylamide exposure and health outcomes has completed, examining potential associations with dementia, Alzheimer's diseas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Karolinska Institutet | Conditions: Dementia, Dementia Alzheimers | Status: COMPLETED